Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Review of the top 5 cardiology studies of 2013-14.

Literature DB >> 26600825

Review of the top 5 cardiology studies of 2013-14.

Arden R Barry¹, Jade E Basaraba¹, Jennifer L Bong¹, Chloe L McMillan¹, Mohamed A Omar¹, Dylan M Pollmann¹, Margaret L Ackman¹.

Abstract

Year: 2015 PMID： 26600825 PMCID： PMC4637849 DOI： 10.1177/1715163515606933

Source DB: PubMed Journal: Can Pharm J (Ott) ISSN： 1715-1635

× No keyword cloud information.

18 in total

1. Eplerenone in patients with systolic heart failure and mild symptoms.

Authors: Faiez Zannad; John J V McMurray; Henry Krum; Dirk J van Veldhuisen; Karl Swedberg; Harry Shi; John Vincent; Stuart J Pocock; Bertram Pitt
Journal: N Engl J Med Date: 2010-11-14 Impact factor: 91.245

2. The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications.

Authors: Gordon W Moe; Justin A Ezekowitz; Eileen O'Meara; Serge Lepage; Jonathan G Howlett; Steve Fremes; Abdul Al-Hesayen; George A Heckman; Howard Abrams; Anique Ducharme; Estrellita Estrella-Holder; Adam Grzeslo; Karen Harkness; Sheri L Koshman; Michael McDonald; Robert McKelvie; Miroslaw Rajda; Vivek Rao; Elizabeth Swiggum; Sean Virani; Shelley Zieroth; J Malcolm O Arnold; Tom Ashton; Michel D'Astous; Michael Chan; Sabe De; Paul Dorian; Nadia Giannetti; Haissam Haddad; Debra L Isaac; Simon Kouz; Marie-Hélène Leblanc; Peter Liu; Heather J Ross; Bruce Sussex; Michel White
Journal: Can J Cardiol Date: 2014-12-19 Impact factor: 5.223

3. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:
Journal: JAMA Date: 2002-12-18 Impact factor: 56.272

4. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.

Authors: Willem J M Dewilde; Tom Oirbans; Freek W A Verheugt; Johannes C Kelder; Bart J G L De Smet; Jean-Paul Herrman; Tom Adriaenssens; Mathias Vrolix; Antonius A C M Heestermans; Marije M Vis; Jan G P Tijsen; Arnoud W van 't Hof; Jurriën M ten Berg
Journal: Lancet Date: 2013-02-13 Impact factor: 79.321

5. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors: Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal: N Engl J Med Date: 2003-03-31 Impact factor: 91.245

6. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors: B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal: N Engl J Med Date: 1999-09-02 Impact factor: 91.245

7. Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.

Authors: Pasi P Karjalainen; Pekka Porela; Antti Ylitalo; Saila Vikman; Kai Nyman; Mari-Anne Vaittinen; Tuukka J Airaksinen; Matti Niemelä; Tero Vahlberg; K E Juhani Airaksinen
Journal: Eur Heart J Date: 2007-01-31 Impact factor: 29.983

Review 8. Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses.

Authors: George C Roush; Theodore R Holford; Achuta K Guddati
Journal: Hypertension Date: 2012-04-23 Impact factor: 10.190